Sara F. Dunne

CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease

Soosung Kang, Garry Cooper, Sara F. Dunne et al. · Nature Communications · 2012 · 166 citations · Full text

Molecular Pharmacology, Molecular Neuroscience, Hyperpolarization (Biology) +8

Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltage-dependent L-type Ca2+ channels CaV1.3 and CaV1.2

Che-Chien Chang, Song Cao, Soosung Kang et al. · Bioorganic & Medicinal Chemistry · 2010 · 53 citations · Full text

Biochemistry, Natural Sciences, Ion Channels +3

Antagonism of L-type Ca2+ channels CaV1.3 and CaV1.2 by 1,4-dihydropyrimidines and 4H-pyrans as dihydropyridine mimics

Soosung Kang, Garry Cooper, Sara F. Dunne et al. · Bioorganic & Medicinal Chemistry · 2013 · 41 citations · Full text

Molecular Pharmacology, Biochemistry, Medicine +5

Genes Involved in Maintaining Mitochondrial Membrane Potential Upon Electron Transport Chain Disruption

Karthik Vasan, Matt Clutter, Sara F. Dunne et al. · Frontiers in Cell and Developmental Biology · 2022 · 31 citations · Full text

Mitophagy, Mitochondrial Dysfunction, Genetics +19

Structure–Activity Relationship of N,N′-Disubstituted Pyrimidinetriones as Ca_V1.3 Calcium Channel-Selective Antagonists for Parkinson’s Disease

Soosung Kang, Garry Cooper, Sara F. Dunne et al. · Journal of Medicinal Chemistry · 2013 · 30 citations · Full text